title: To the Editor--Propranolol, a β-adrenoreceptor blocker, prevents arrhythmias also by its sodium channel blocking effect.
authors.affiliation: Centre for Cardiovascular Sciences University of Birmingham Birmingham, United Kingdom; University Hospital Muenster, Germany. Electronic address: L.Fabritz@bham.ac.uk.
authors.forename: Larissa
authors.initials: L
authors.lastname: Fabritz
authors.affiliation: Georgetown University and VA Hospital Washington, DC.
authors.forename: Michael R
authors.initials: MR
authors.lastname: Franz
authors.affiliation: KU Leuven Leuven, Belgium.
authors.forename: Edward
authors.initials: E
authors.lastname: Carmeliet
authors.affiliation: Centre for Cardiovascular Sciences University of Birmingham Birmingham, United Kingdom; University Hospital Muenster, Germany.
authors.forename: Paulus
authors.initials: P
authors.lastname: Kirchhof
mesh_terms: D000818:Animals; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D004562:Electrocardiography / Q000187:drug effects*; D006801:Humans; D008133:Long QT Syndrome / Q000188:drug therapy*; D011433:Propranolol / Q000008:administration & dosage*
chemical_list: D011433:Propranolol